mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.4 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |